Understanding Gene Mutations in Your Metastatic Breast Cancer Diagnosis Is Crucial to Your Treatment

Updated January 6th, 2023

Understanding Gene Mutations in Your Metastatic Breast Cancer Diagnosis Is Crucial to Your Treatment

NOW
PLAYING
CDK4/6 Inhibitors for Breast Cancer Explained
NOW
PLAYING
PARP Inhibitors Before Surgery: A New Treatment Option for Ovarian Cancer Patients?
NOW
PLAYING
Beloved Principal Battling 2 Cancers Gets Heartwarming Homecoming From Students
NOW
PLAYING
HER2-Low Metastatic Breast Cancers Can Benefit From Enhertu
NOW
PLAYING
How Does Trodelvy Work For HER2-Negative, HR-Positive Metastatic Breast Cancer? Looking into the Newly Approved Option
NOW
PLAYING
Elacestrant (Orserdu) Offers Hope for Patients With a Stubborn Form of Metastatic Breast Cancer

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... breast cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: HER2- and HER2 Low - Dramatic Change in Treatment Paradigm

SEE MORE   

Later Stage Treatment: HER2- and HER2 Low - Dramatic Change in Treatment Paradigm

  • Experts say HER2- metastatic breast cancer patients should go back to their doctors to see whether their cancer is actually HER2 Low
  • Some women previously classified as HER2- may now qualify for treatment with a new drug called Enhertu that can extend overall survival rates
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.